Skip to main content
Fig. 9 | Clinical Epigenetics

Fig. 9

From: Characterization of molecular subtypes based on chromatin regulators and identification of the role of NPAS2 in lung adenocarcinoma

Fig. 9

Knockdown of NPAS2 impeded proliferative activity of LUAD cells. A Expression of NPAS2 in BEAS-2b, A549, PC-9, HCC827, and H1975 cells. B–D Efficacy of siRNAs in suppressing expression of NPAS2 in A549 and PC-9 cells. E–F OD values of A549 and PC-9 cells in CCK8 assay after knockdown of NPAS2. G–H Proliferative activity of A549 and PC-9 cells in EdU assay after knockdown of NPAS2. I–J Colony formation assay for A549 and PC-9 cells after knockdown of NPAS2. *p < 0.05, ** p < 0.01, *** p < 0.001

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us